Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma

Objective. Patients with gastroenteropancreatic neuroendocrine carcinoma (NEC) have a poor prognosis. Platinum-based combination chemotherapy is commonly used as first-line treatment; however, the role of salvage chemotherapy remains unknown. This study aimed to analyze the efficacy and safety of am...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Takayuki, Hosokawa, Ayumu, Yoshita, Hiroki, Ueda, Akira, Kajiura, Shinya, Mihara, Hiroshi, Nanjo, Sohachi, Fujinami, Haruka, Nishikawa, Jun, Ogawa, Kohei, Nakajima, Takahiko, Imura, Johji, Sugiyama, Toshiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493294/
https://www.ncbi.nlm.nih.gov/pubmed/26199623
http://dx.doi.org/10.1155/2015/425876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493294/
https://www.ncbi.nlm.nih.gov/pubmed/26199623
http://dx.doi.org/10.1155/2015/425876

Ejemplares similares